Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11026 results:
[ Συντάκτης(Asc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Z
Zarogoulidis, P., Lampaki S., Yarmus L., Kioumis I., Pitsiou G., Katsikogiannis N., et al. (2014).  Interleukin-7 and interleukin-15 for cancer.. J Cancer. 5(9), 765-73.
Zarogoulidis, P., Darwiche K., Hohenforst-Schmidt W., Huang H., Li Q., Freitag L., et al. (2013).  Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancer.. Future Oncol. 9(8), 1171-94.
Zarogoulidis, P., Athanasiou E., Tsiouda T., Hatzibougias D., Huang H., Bai C., et al. (2017).  Immunotherapy "Shock" a case series of PD-L1 100% and pembrolizumab first-line treatment.. Respir Med Case Rep. 22, 197-202.
Zarogoulidis, P., Sapalidis K., Fyntanidou V., Kosmidis C., Amaniti A., Koulouris C., et al. (2019).  Evaluating the use of elastography in endobronchial ultrasound technique as a diagnostic approach for mesothorax lymphadenopathy. Expert Review of Respiratory Medicine. 1375(121), 1153 - 1159.
Zarogoulidis, P., Cheva A., Zarampouka K., Huang H., Li C., Huang Y., et al. (2013).  Tocopherols and tocotrienols as anticancer treatment for lung cancer: future nutrition.. J Thorac Dis. 5(3), 349-52.
Zarogoulidis, P., Glaros D., Kioumis I., Terzi E., Porpodis K., Tsiotsios A., et al. (2012).  Clinical differences between influenza A (H1N1) virus and respiratory infection between the two waves in 2009 and 2010.. Int J Gen Med. 5, 675-82.
Zarogoulidis, P., Kontakiotis T., Tsakiridis K., Karanikas M., Simoglou C., Porpodis K., et al. (2012).  Difficult airway and difficult intubation in postintubation tracheal stenosis: a case report and literature review.. Ther Clin Risk Manag. 8, 279-86.
Zarogoulidis, P., Yarmus L., Darwiche K., Walter R., Huang H., Li Z., et al. (2013).  Interleukin-6 cytokine: a multifunctional glycoprotein for cancer.. Immunome Res. 9(62), 16535.
Zarogoulidis, P., Lampaki S., J Turner F., Huang H., Kakolyris S., Syrigos K., et al. (2014).  mTOR pathway: A current, up-to-date mini-review (Review).. Oncol Lett. 8(6), 2367-2370.
Zarogoulidis, P., Kontakiotis T., & Zarogoulidis K. (2012).  Inhaled gene therapy in lung cancer: "as for the future, our task is not to foresee it, but to enable it".. Ther Deliv. 3(8), 919-21.
Zarogoulidis, K., Porpodis K., Domvri K., Eleftheriadou E., Ioannidou D., & Zarogoulidis P. (2016).  Diagnosing and treating pancoast tumors.. Expert Rev Respir Med. 10(12), 1255-1258.
Zarogoulidis, P., Kioumis I., Pitsiou G., Porpodis K., Lampaki S., Papaiwannou A., et al. (2014).  Pneumothorax: from definition to diagnosis and treatment.. J Thorac Dis. 6(Suppl 4), S372-6.
Zarogoulidis, P., Petridis D., Ritzoulis C., Darwiche K., Kioumis I., Porpodis K., et al. (2013).  Internal mouthpiece designs as a future perspective for enhanced aerosol deposition. Comparative results for aerosol chemotherapy and aerosol antibiotics.. Int J Pharm. 456(2), 325-31.
Zarogoulidis, P., Hohenforst-Schmidt W., Darwiche K., Krauss L., Sparopoulou D., Sakkas L., et al. (2013).  2-diethylaminoethyl-dextran methyl methacrylate copolymer nonviral vector: still a long way toward the safety of aerosol gene therapy.. Gene Ther. 20(10), 1022-8.
Zarogoulidis, P., Tsakiridis K., Karapantzou C., Lampaki S., Kioumis I., Pitsiou G., et al. (2015).  Use of proteins as biomarkers and their role in carcinogenesis.. J Cancer. 6(1), 9-18.
Zarogoulidis, P., Laskou S., Katsaounis A., Pavlidis E., Giannakidis D., Koulouris C., et al. (2018).  Esophagus lyomyoma diagnosed with convex endobronchial ultrasound (EBUS).. Respir Med Case Rep. 24, 95-97.
Zarogoulidis, P., Constantinidis T., Steiropoulos P., Papanas N., Zarogoulidis K., & Maltezos E. (2011).  Are there any differences in clinical and laboratory findings on admission between H1N1 positive and negative patients with flu-like symptoms?. BMC Res Notes. 4, 4.
Zarogoulidis, K., Ziogas E., Boutsikou E., Zarogoulidis P., Darwiche K., Kontakiotis T., et al. (2013).  Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a phase II, randomized study.. Drug Des Devel Ther. 7, 611-7.
Zarogoulidis, P., Darwiche K., Walter R., Li Q., Teschler H., Freitag L., et al. (2013).  Research spotlight: sirolimus-coated stents for airway tracheal stenosis: a future 3D model concept with today's knowledge.. Ther Deliv. 4(9), 1093-7.
Zarogoulidis, P., Huang H., Bai C., Kosmidis C., Trakada G., Veletza L., et al. (2017).  Endobronchial ultrasound convex probe for lymphoma, sarcoidosis, lung cancer and other thoracic entities. A case series.. Respir Med Case Rep. 22, 187-196.
Zarogoulidis, P., Papadopoulos V., Maragouli E., Papatsibas G., Karapantzos I., Bai C., et al. (2018).  Tumor heterogenicity: multiple needle biopsies from different lesion sites-key to successful targeted therapy and immunotherapy.. Transl Lung Cancer Res. 7(Suppl 1), S46-S48.
Zarogoulidis, P., Eleftheriadou E., Sapardanis I., Zarogoulidou V., Lithoxopoulou H., Kontakiotis T., et al. (2012).  Feasibility and effectiveness of inhaled carboplatin in NSCLC patients.. Invest New Drugs. 30(4), 1628-40.
Zarogoulidis, P., Petridis D., Sapalidis K., Tsakiridis K., Baka S., Vagionas A., et al. (2020).  Lung cancer biopsies: Comparison between simple 22G, 22G upgraded and 21G needle for EBUS-TBNA.. J Cancer. 11(21), 6454-6459.
Zarogoulidis, P., Darwiche K., Sakkas A., Yarmus L., Huang H., Li Q., et al. (2013).  Suicide Gene Therapy for Cancer - Current Strategies.. J Genet Syndr Gene Ther. 4,
Zarogoulidis, P., Huang H., Tsiouda T., Sardeli C., Trakada G., Veletza L., et al. (2017).  Immunotherapy "Shock" with vitiligo due to nivolumab administration as third line therapy in lung adenocarcinoma.. Respir Med Case Rep. 22, 283-286.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.